FDA commissioner Martin Makary says there are no current plans to restrict access to the abortion drug mifepristone.
Abbott recalls its HeartMate Mobile Power Unit to remove the component due to instances where the device experiences a sudden power loss.
The Association for Clinical Oncology tells the new leaders of FDA, NIH, and CMS it looks forward to working with them on behalf of cancer research an...
Bristol Myers Squib says its Cobenfy showed positive results in the Phase 3 ARISE trial as an adjunctive therapy to atypical antipsychotics for patien...
Former FDA associate commissioner Peter Pitts calls on the agency to revise drug labels with obesity safety and effectiveness information.
Lilly sues four additional drug compounders for illegally selling copies of its weight loss and diabetes drugs.
The catheter is part of a system intended for intravascular imaging of coronary arteries.
Novavax says its Covid-19 vaccine BLA is being held up while FDA seeks to conclude a post-marketing commitment from the company.
